Targets › NOS
1 program from 1 company in 1 trial: 1 Phase 1; Other; next expected readout Oct 2027.
Open in Phaseline: the race on NOS, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| University of Pennsylvania | [18F]NOS Nitric oxide synthase (NOS) radiotracer | NOS | Phase 1 | Smoking, Cigarette | Oct 2027 |
Smoking, Cigarette (1)
small molecule (1)
University of Pennsylvania (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.